Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-21

FDA Approved: URSO 250 — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved Allergan's supplemental application for URSO 250 (ursodiol), adding a 250 mg strength to the product label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • URSO 250 (ursodiol)

Snippet

SUPPL AP for URSO 250 (URSODIOL)